Opportunity Information: Apply for RFA IP 12 004
Apply for RFA IP 12 004
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Identifying Reasons for Racial/Ethnic Disparities with Completing the HPV Vaccine Series among Adolescent Females" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.185 Immunization Research, Demonstration, Public Information and EducationTraining and Clinical Skills Improvement Projects.
- This funding opportunity was created on Jan 9, 2012 and posted on Jan 9, 2012.
- Applicants must submit their applications by Mar 28, 2012. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $600,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $300,000.00 in funding.
- The number of recipients for this funding is limited to 2 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- Eligible Applicants Eligible Organizations Higher Education Institutions Public/State Controlled Institutions of Higher Education Private Institutions of Higher Education The following types of Higher Education Institutions are always encouraged to apply for CDC support as Public or Private Institutions of Higher Education Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Tribally Controlled Colleges and Universities (TCCUs) Alaska Native and Native Hawaiian Serving Institutions Nonprofits Other Than Institutions of Higher Education Nonprofits (Other than Institutions of Higher Education) Governments State Governments County Governments City or Township Governments Special District Governments Indian/Native American Tribal Governments (Federally Recognized) Indian/Native American Tribal Governments (Other than Federally Recognized) Eligible Agencies of the Federal Government U.S. Territory or Possession Other Independent School Districts Public Housing Authorities/Indian Housing Authorities Native American tribal organizations (other than Federally recognized tribal governments) Faith based or Community based Organizations Regional Organizations Bona Fide Agents A Bona Fide Agent is an agency/organization identified by the state as eligible to submit an application under the state eligibility in lieu of a state application. If applying as a bona fide agent of a state or local government, a legal, binding agreement from the state or local government as documentation of the status is required. Attach with Other Attachment Forms when submitting via www.grants.gov. Non domestic (non U.S.) Entities (Foreign Organizations) are not eligible to apply. Foreign (non U.S.) components of U.S. Organizations are not allowed.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
This CDC funding opportunity (RFA IP 12-004) supports research focused on understanding why adolescent females do not start or do not finish the HPV vaccine series, and why those patterns differ across racial and ethnic groups. The core purpose is to identify the specific parent-level factors that contribute to disparities in HPV vaccination among girls ages 11 to 18, with an emphasis on differences between White, Black, and Hispanic populations, and on whether barriers vary by poverty level. The project is framed as an immunization research and demonstration effort intended to generate practical, evidence-based insight that can inform future public health strategies to close vaccination gaps and improve series completion.
Applicants are required to build a research plan around the first major objective described in the announcement: assessing factors among parents that lead to (1) not initiating HPV vaccination at all, or (2) starting but failing to complete the full vaccine series. The expectation is not just to list barriers, but to analyze whether the reasons differ in type or importance depending on race/ethnicity (specifically Whites, Blacks, and Hispanics) and depending on economic conditions such as poverty status. In other words, the study should be designed to tease apart whether different groups face different obstacles, whether the same obstacles affect groups to different degrees, and how poverty interacts with these patterns.
A key requirement is that the study setting and population be clearly defined and intentionally selected to support disparity-focused analysis. The application must describe the geographic area or areas included, covering details such as population size, the level of racial and ethnic diversity, how income levels are distributed, and whether the setting is urban, suburban, rural, or mixed. The CDC is looking for applicants who can demonstrate that their chosen locations will allow meaningful comparisons across groups and socioeconomic levels, rather than producing results that are too narrow or not generalizable to the disparity question.
The applicant must also ensure the study includes parents from at least one racial/ethnic minority group (Black and/or Hispanic) in addition to White parents. This requirement is meant to guarantee that the study can directly evaluate disparity-related questions instead of treating minority participation as optional. In addition, the study must include parents of adolescents who receive vaccines in both public clinic settings and private provider offices. That design element reflects the reality that access points and care experiences can vary sharply between public and private sectors, and those differences may influence whether families start or complete the HPV series.
The award mechanism is a cooperative agreement, meaning CDC typically expects substantial involvement beyond simply providing funds, often including collaboration on study approach, monitoring, and alignment with program goals. The opportunity was posted January 9, 2012, with a closing date of March 28, 2012, and it was archived April 27, 2012. CDC anticipated making two awards, with total estimated funding of $600,000 and an award ceiling of $300,000 per award. There is no cost-sharing or matching requirement, which lowers the financial barrier for applicants that may not have discretionary funds to contribute.
Eligibility is broad across U.S.-based organizations and includes public and private higher education institutions, nonprofits, and multiple levels of government (state, county, city/township, special districts, and tribal governments). The announcement specifically encourages applications from Hispanic-serving institutions, historically Black colleges and universities, tribally controlled colleges and universities, and Alaska Native and Native Hawaiian serving institutions. Other eligible applicants include independent school districts, public housing authorities, faith-based and community-based organizations, regional organizations, and bona fide agents formally designated by a state or local government (with required documentation). Non-U.S. entities are not eligible, and foreign components of U.S. organizations are not allowed.
For access issues or administrative support, the notice lists the CDC Procurement and Grants Office as the contact point (TIMS, 770-488-2700, PGOTIM@cdc.gov).
Frequently Asked Questions (FAQs)
What is the CDC funding opportunity RFA IP 12-004 about?
This opportunity supports research to understand why adolescent females do not start the HPV vaccine series or do not finish it, and why those patterns differ across racial and ethnic groups. The work is positioned as immunization research and a demonstration effort intended to produce practical, evidence-based insight that can inform future public health strategies to reduce disparities and improve HPV series completion.
What is the main purpose of the research?
The core purpose is to identify specific parent-level factors that contribute to disparities in HPV vaccination among girls ages 11 to 18. The focus is on differences between White, Black, and Hispanic populations and on whether barriers vary by poverty level.
What is the primary objective applicants must address?
Applicants are required to build their research plan around the first major objective described in the announcement: assessing factors among parents that lead to (1) not initiating HPV vaccination at all, or (2) starting but failing to complete the full HPV vaccine series.
Does the CDC want a simple list of barriers to HPV vaccination?
No. The expectation is to analyze whether the reasons for not starting or not completing the HPV vaccine series differ in type or importance depending on race/ethnicity (specifically Whites, Blacks, and Hispanics) and depending on economic conditions such as poverty status. The study design should allow comparisons that show whether different groups face different obstacles, whether the same obstacles affect groups to different degrees, and how poverty interacts with these patterns.
Which age group is the research focused on?
The project focuses on girls ages 11 to 18, specifically through the lens of parent-level factors that influence HPV vaccination initiation and completion.
Which racial and ethnic groups are explicitly emphasized for disparity analysis?
The opportunity emphasizes differences among White, Black, and Hispanic populations. The study must include parents from at least one racial/ethnic minority group (Black and/or Hispanic) in addition to White parents.
Is it required to include minority participants in the study?
Yes. The applicant must ensure the study includes parents from at least one racial/ethnic minority group (Black and/or Hispanic) in addition to White parents. This is intended to ensure the study can directly evaluate disparity-related questions.
Does the opportunity require analysis by poverty level or economic status?
Yes. The announcement emphasizes examining whether barriers vary by poverty level and how poverty interacts with racial/ethnic differences in HPV vaccine initiation and series completion.
How should applicants choose and describe the study setting?
The study setting and population must be clearly defined and intentionally selected to support disparity-focused analysis. The application should describe the geographic area(s) included and provide details such as population size, racial and ethnic diversity, how income levels are distributed, and whether the setting is urban, suburban, rural, or mixed. The CDC is looking for locations that allow meaningful comparisons across groups and socioeconomic levels.
Does the study need to include both public and private vaccination settings?
Yes. The study must include parents of adolescents who receive vaccines in both public clinic settings and private provider offices. This requirement reflects that access points and care experiences can differ between public and private sectors and may influence whether families start or complete the HPV series.
What type of award mechanism is used?
The award mechanism is a cooperative agreement. This typically means the CDC expects substantial involvement beyond providing funds, such as collaboration on study approach, monitoring, and alignment with program goals.
How many awards did CDC anticipate making, and what was the funding amount?
CDC anticipated making two awards. Total estimated funding was $600,000, with an award ceiling of $300,000 per award.
Is cost-sharing or matching required?
No. There is no cost-sharing or matching requirement for this opportunity.
When was the opportunity posted, and what were the key dates?
The opportunity was posted on January 9, 2012. The closing date was March 28, 2012. It was archived on April 27, 2012.
Who is eligible to apply?
Eligibility is broad across U.S.-based organizations. Eligible applicants include public and private higher education institutions, nonprofits, and multiple levels of government (state, county, city/township, special districts, and tribal governments). Other eligible applicants include independent school districts, public housing authorities, faith-based and community-based organizations, regional organizations, and bona fide agents formally designated by a state or local government (with required documentation).
Are any organizations specifically encouraged to apply?
Yes. The announcement specifically encourages applications from Hispanic-serving institutions, historically Black colleges and universities, tribally controlled colleges and universities, and Alaska Native and Native Hawaiian serving institutions.
Are non-U.S. organizations eligible?
No. Non-U.S. entities are not eligible.
Are foreign components of U.S. organizations allowed?
No. Foreign components of U.S. organizations are not allowed.
What documentation is needed if applying as a bona fide agent of a government?
The eligibility description notes that bona fide agents formally designated by a state or local government are eligible, with required documentation. The specific documentation details are not provided in the summary information here, but the application would need to include the required designation documentation.
What is the CDC contact for access issues or administrative support?
The contact point listed is the CDC Procurement and Grants Office: TIMS, 770-488-2700, PGOTIM@cdc.gov.
What kinds of comparisons should the study be able to make?
Based on the requirements described, the study should support comparisons of parent-level factors related to (1) not initiating HPV vaccination and (2) not completing the series, with analyses that distinguish patterns by race/ethnicity (Whites, Blacks, Hispanics), by poverty level, and across public clinic versus private provider vaccination settings.
Browse more opportunities from the same category: Health
Next opportunity: Intervention Study to Increase Use of Standing Orders Programs for Vaccinating Adults in Physician Office Settings
Previous opportunity: GROUND BASED STUDIES IN SPACE RADIOBIOLOGY
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA IP 12 004
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (RFA IP 12 004) also looked into and applied for these:
| Funding Opportunity |
|---|
| Intervention Study to Increase Use of Standing Orders Programs for Vaccinating Adults in Physician Office Settings Apply for RFA IP 12 005 Funding Number: RFA IP 12 005 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $300,000 |
| Affordable Care Act Maternal, Infant, and Early Childhood Home Visiting Research Network Apply for HRSA 12 158 Funding Number: HRSA 12 158 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Multidisciplinary Clinical Research Centers (P60) Apply for RFA AR 13 001 Funding Number: RFA AR 13 001 Agency: National Institutes of Health Category: Health Funding Amount: $800,000 |
| NINDS Exploratory Clinical Trials for Small Business (STTR R42) Apply for PAR 12 072 Funding Number: PAR 12 072 Agency: National Institutes of Health Category: Health Funding Amount: $100,000 |
| NINDS Exploratory Clinical Trials for Small Business (SBIR R44) Apply for PAR 12 073 Funding Number: PAR 12 073 Agency: National Institutes of Health Category: Health Funding Amount: $150,000 |
| NINDS Competing Renewal Awards of STTR Phase II Grants (Phase IIB) for Exploratory Clinical Trials (STTR R42) Apply for PAR 12 074 Funding Number: PAR 12 074 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NINDS Competing Renewal Awards of SBIR Phase II Grants (Phase IIB) for Exploratory Clinical Trials (SBIR R44) Apply for PAR 12 075 Funding Number: PAR 12 075 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NINDS Competing Renewal Awards of SBIR Phase II (Phase IIB) Grants (SBIR R44) Apply for PAR 12 077 Funding Number: PAR 12 077 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NINDS Competing Renewal Awards of STTR Phase II (Phase IIB) Grants (STTR R42) Apply for PAR 12 076 Funding Number: PAR 12 076 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| CHILDRENS HEALTH INSURANCE PROGRAM REAUTHORIZATION ACT (CHIPRA)PROSPECTIVE PAYMENT SYSTEM (PPS) FOR FEDERALLY QUALIFIED HEALTH CENTERS (FQHCs) AND RURAL HEALTH CLINICS (RHCs) TRANSITION GRANTS SECOND RELEASE Apply for CMS 1Z0 12 001 Funding Number: CMS 1Z0 12 001 Agency: Centers for Medicare Medicaid Services Category: Health Funding Amount: $500,000 |
| Molecular Characterization of Salivary Gland Tumors (R21) Apply for RFA DE 12 012 Funding Number: RFA DE 12 012 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Molecular Characterization of Salivary Gland Tumors (R01) Apply for RFA DE 12 011 Funding Number: RFA DE 12 011 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Conducting Research on Moderate Acute Malnutrition in Humanitarian Emergencies Apply for RFA GH 12 006 Funding Number: RFA GH 12 006 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $2,000,000 |
| Service Area Competition Additional Area (SAC AA) (Anchorage, AK) Apply for HRSA 12 169 Funding Number: HRSA 12 169 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Dental Reimbursement Program Apply for HRSA 12 080 Funding Number: HRSA 12 080 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Biodemography of Aging (R21) Apply for PAR 12 079 Funding Number: PAR 12 079 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Biodemography of Aging (R01) Apply for PAR 12 078 Funding Number: PAR 12 078 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Biodemography of Aging (R03) Apply for PAR 12 080 Funding Number: PAR 12 080 Agency: National Institutes of Health Category: Health Funding Amount: $100,000 |
| Leadership Group for a Clinical Research Network on Antibacterial Resistance (UM1) Apply for RFA AI 12 019 Funding Number: RFA AI 12 019 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NINDS Institutional Center Core Grants to Support Neuroscience Research (P30) Apply for PAR 12 081 Funding Number: PAR 12 081 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA IP 12 004", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.